HIMS
Hims & Hers Health, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$27.49
−1.19%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
113.6x
EV/EBITDA
−93.2x
Market Cap
$6.41B
MomentumView details →
1D Return
−1.19%
YTD Return
−14.75%
RSI (14)
43.3
ValuationView details →
P/E (Fwd)
113.6x
EV/EBITDA
−93.2x
Market Cap
$6.41B
RSI (14)
43.3
MomentumView details →
1D Return
−1.19%
YTD Return
−14.75%
SummaryUpdated Jun 1, 2026
Hims & Hers Health, Inc. (NYSE:HIMS) is a San Francisco-based telehealth company that operates a multi-specialty digital health platform connecting consumers directly to licensed healthcare professionals. Founded in 2017, the company went public in 2019 and has rapidly expanded from its initial focus on men's sexual health to become a comprehensive telehealth provider serving over 2.4 million subscribers across multiple health specialties including weight management, dermatology, mental health, and sexual wellness.
Similar companies
Latest newsMore news →
A class action lawsuit was filed against Hims & Hers Health, Inc. alleging that the company made materially false and misleading statements during the Class Period, causing investor harm.2h agoA class action lawsuit was filed against Hims & Hers Health, Inc. on behalf of investors who purchased its securities between August 4, 2025 and July 29, 2026.22h agoHims & Hers began offering branded GLP-1 weight-loss drugs and men's health treatments in Australia on Monday, expanding its international business.4d ago